Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

New Fissure-attached Nodules in Lung Cancer Screening: A Brief Report from The NELSON Study.

Han D, Heuvelmans MA, van der Aalst CM, van Smoorenburg LH, Dorrius MD, Rook M, Nackaerts K, Walter JE, Groen HJM, Vliegenthart R, de Koning HJ, Oudkerke M.

J Thorac Oncol. 2019 Oct 10. pii: S1556-0864(19)33521-X. doi: 10.1016/j.jtho.2019.09.193. [Epub ahead of print]

PMID:
31606605
2.

Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17/04 trial.

Riesterer O, Frank Ciernik I, Stahel RA, Xyrafas A, Aebersold DM, Plasswilm L, Mahmut Ozsahin E, Zwahlen DR, Nackaerts K, Zimmermann F, Sabrina Stark L, Weder W, Krayenbuehl J; Swiss Group for Clinical Cancer Research (SAKK).

Radiother Oncol. 2019 Sep;138:121-125. doi: 10.1016/j.radonc.2019.05.024. Epub 2019 Jun 25.

PMID:
31252293
3.

Severe intestinal ischemia during chemotherapy for small cell lung cancer.

Legius B, Nackaerts K.

Lung Cancer Manag. 2017 Dec;6(3):87-91. doi: 10.2217/lmt-2017-0016. Epub 2017 Dec 1.

4.

Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.

Walter JE, Heuvelmans MA, Ten Haaf K, Vliegenthart R, van der Aalst CM, Yousaf-Khan U, van Ooijen PMA, Nackaerts K, Groen HJM, De Bock GH, de Koning HJ, Oudkerk M.

Thorax. 2019 Mar;74(3):247-253. doi: 10.1136/thoraxjnl-2018-212152. Epub 2018 Dec 27.

PMID:
30591535
5.

Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.

Frick AE, Nackaerts K, Moons J, Lievens Y, Verbeken E, Lambrecht M, Coolen J, Dooms C, Vansteenkiste J, De Leyn P, Nafteux P.

Eur J Cardiothorac Surg. 2019 May 1;55(5):934-941. doi: 10.1093/ejcts/ezy385.

PMID:
30535191
6.

An uncommon histopathological diagnosis.

Bode H, Sciot R, Werbrouck E, Geusens E, Deroose CM, Nackaerts K.

Breathe (Sheff). 2018 Dec;14(4):311-316. doi: 10.1183/20734735.027418.

7.

Hotspots of malignant pleural mesothelioma in Western Europe.

Nuyts V, Nawrot T, Nemery B, Nackaerts K.

Transl Lung Cancer Res. 2018 Oct;7(5):516-519. doi: 10.21037/tlcr.2018.10.01. Review.

8.

Real-life treatment practice for malignant pleural mesothelioma in Belgium.

Rosskamp M, Macq G, Nackaerts K, Praet M, Van Eycken L, Van Meerbeeck JP, De Schutter H.

Lung Cancer. 2018 Nov;125:258-264. doi: 10.1016/j.lungcan.2018.10.009. Epub 2018 Oct 9.

PMID:
30429030
9.

Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.

Walter JE, Heuvelmans MA, de Bock GH, Yousaf-Khan U, Groen HJM, van der Aalst CM, Nackaerts K, van Ooijen PMA, de Koning HJ, Vliegenthart R, Oudkerk M.

Lung Cancer. 2018 Nov;125:103-108. doi: 10.1016/j.lungcan.2018.05.007. Epub 2018 May 14.

10.

Ramsay Hunt syndrome: a rare complication of herpes zoster infection in a lung cancer patient.

Mercier T, Deslypere G, Nackaerts K.

Acta Clin Belg. 2019 Oct;74(5):355-358. doi: 10.1080/17843286.2018.1517076. Epub 2018 Sep 6.

PMID:
30189789
11.

Assessing the completeness and correctness of the registration of malignant mesothelioma in Belgium.

Rosskamp M, De Schutter H, Henau K, Nackaerts K, Van Meerbeeck JP, Praet M, Van Eycken L.

Lung Cancer. 2018 Aug;122:38-43. doi: 10.1016/j.lungcan.2018.05.018. Epub 2018 May 21.

PMID:
30032843
12.

RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue.

Reynders K, Wauters E, Moisse M, Decaluwé H, De Leyn P, Peeters S, Lambrecht M, Nackaerts K, Dooms C, Janssens W, Vansteenkiste J, Lambrechts D, De Ruysscher D.

Radiat Oncol. 2018 Jul 17;13(1):131. doi: 10.1186/s13014-018-1075-1.

13.

A Randomized Clinical Trial of Flex 19G Needles versus 22G Needles for Endobronchial Ultrasonography in Suspected Lung Cancer.

Dooms C, Vander Borght S, Yserbyt J, Testelmans D, Wauters E, Nackaerts K, Vansteenkiste J, Verbeken E, Weynand B.

Respiration. 2018;96(3):275-282. doi: 10.1159/000489473. Epub 2018 Jun 29.

PMID:
29961053
14.

New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial.

Walter JE, Heuvelmans MA, Yousaf-Khan U, Dorrius MD, Thunnissen E, Schermann A, Groen HJM, van der Aalst CM, Nackaerts K, Vliegenthart R, de Koning HJ, Oudkerk M.

J Thorac Oncol. 2018 Sep;13(9):1410-1414. doi: 10.1016/j.jtho.2018.05.006. Epub 2018 Jul 12.

15.

Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.

Walter JE, Heuvelmans MA, Bock GH, Yousaf-Khan U, Groen HJM, Aalst CMV, Nackaerts K, Ooijen PMAV, Koning HJ, Vliegenthart R, Oudkerk M.

Thorax. 2018 Aug;73(8):741-747. doi: 10.1136/thoraxjnl-2017-211376. Epub 2018 Apr 16.

PMID:
29661918
16.

An unusual presentation of a more common disease entity.

Van de Kerkhove C, De Wever W, Verbeken EK, Deroose C, Nackaerts K.

Breathe (Sheff). 2018 Mar;14(1):49-53. doi: 10.1183/20734735.013417.

17.

Is central lung tumour location really predictive for occult mediastinal nodal disease in (suspected) non-small-cell lung cancer staged cN0 on 18F-fluorodeoxyglucose positron emission tomography-computed tomography?

Decaluwé H, Moons J, Fieuws S, De Wever W, Deroose C, Stanzi A, Depypere L, Nackaerts K, Coolen J, Lambrecht M, Verbeken E, De Ruysscher D, Vansteenkiste J, Van Raemdonck D, De Leyn P, Dooms C; Leuven Lung Cancer Group.

Eur J Cardiothorac Surg. 2018 Jul 1;54(1):134-140. doi: 10.1093/ejcts/ezy018.

PMID:
29447330
18.

Exhaled breath to screen for malignant pleural mesothelioma: a validation study.

Lamote K, Vynck M, Thas O, Van Cleemput J, Nackaerts K, van Meerbeeck JP.

Eur Respir J. 2017 Dec 21;50(6). pii: 1700919. doi: 10.1183/13993003.00919-2017. Print 2017 Dec.

19.

Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study.

Lamote K, Brinkman P, Vandermeersch L, Vynck M, Sterk PJ, Van Langenhove H, Thas O, Van Cleemput J, Nackaerts K, van Meerbeeck JP.

Oncotarget. 2017 Sep 27;8(53):91593-91602. doi: 10.18632/oncotarget.21335. eCollection 2017 Oct 31.

20.

Posterior reversible encephalopathy syndrome possibly induced by pemetrexed maintenance therapy for lung cancer: a case report and literature review.

Smets GJ, Loyson T, Van Paesschen W, Demaerel P, Nackaerts K.

Acta Clin Belg. 2018 Oct;73(5):382-388. doi: 10.1080/17843286.2017.1403103. Epub 2017 Nov 24. Review.

PMID:
29173113
21.

Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.

Heuvelmans MA, Walter JE, Peters RB, Bock GH, Yousaf-Khan U, Aalst CMV, Groen HJM, Nackaerts K, Ooijen PMV, Koning HJ, Oudkerk M, Vliegenthart R.

Lung Cancer. 2017 Nov;113:45-50. doi: 10.1016/j.lungcan.2017.08.023. Epub 2017 Sep 1.

22.

Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors.

van Cann T, Loyson T, Verbiest A, Clement PM, Bechter O, Willems L, Spriet I, Coropciuc R, Politis C, Vandeweyer RO, Schoenaers J, Debruyne PR, Dumez H, Berteloot P, Neven P, Nackaerts K, Woei-A-Jin FJSH, Punie K, Wildiers H, Beuselinck B.

Support Care Cancer. 2018 Mar;26(3):869-878. doi: 10.1007/s00520-017-3903-5. Epub 2017 Sep 30.

PMID:
28963584
23.

Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial.

Maio M, Scherpereel A, Calabrò L, Aerts J, Cedres Perez S, Bearz A, Nackaerts K, Fennell DA, Kowalski D, Tsao AS, Taylor P, Grosso F, Antonia SJ, Nowak AK, Taboada M, Puglisi M, Stockman PK, Kindler HL.

Lancet Oncol. 2017 Sep;18(9):1261-1273. doi: 10.1016/S1470-2045(17)30446-1. Epub 2017 Jul 17.

PMID:
28729154
24.

Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab.

Loyson T, Van Cann T, Schöffski P, Clement PM, Bechter O, Spriet I, Coropciuc R, Politis C, Vandeweyer RO, Schoenaers J, Dumez H, Berteloot P, Neven P, Nackaerts K, Woei-A-Jin FJSH, Punie K, Wildiers H, Beuselinck B.

Acta Clin Belg. 2018 Apr;73(2):100-109. doi: 10.1080/17843286.2017.1348001. Epub 2017 Jul 10.

PMID:
28693379
25.

Quantifying asbestos in lung tissue: what debate?

Nemery B, Nuyts V, Nackaerts K.

Eur Respir J. 2017 Jun 29;49(6). pii: 1700861. doi: 10.1183/13993003.00861-2017. Print 2017 Jun. No abstract available.

26.

Geriatric Assessment and Functional Decline in Older Patients with Lung Cancer.

Decoster L, Kenis C, Schallier D, Vansteenkiste J, Nackaerts K, Vanacker L, Vandewalle N, Flamaing J, Lobelle JP, Milisen K, De Grève J, Wildiers H.

Lung. 2017 Oct;195(5):619-626. doi: 10.1007/s00408-017-0025-2. Epub 2017 Jun 20.

PMID:
28634893
27.

Quantification of growth patterns of screen-detected lung cancers: The NELSON study.

Heuvelmans MA, Vliegenthart R, de Koning HJ, Groen HJM, van Putten MJAM, Yousaf-Khan U, Weenink C, Nackaerts K, de Jong PA, Oudkerk M.

Lung Cancer. 2017 Jun;108:48-54. doi: 10.1016/j.lungcan.2017.02.021. Epub 2017 Mar 1.

28.

A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer.

Glisson B, Besse B, Dols MC, Dubey S, Schupp M, Jain R, Jiang Y, Menon H, Nackaerts K, Orlov S, Paz-Ares L, Ramlau R, Tang R, Zhang Y, Zhu M.

Clin Lung Cancer. 2017 Nov;18(6):615-625.e8. doi: 10.1016/j.cllc.2017.05.007. Epub 2017 May 10.

PMID:
28601388
29.

Risk stratification based on screening history: the NELSON lung cancer screening study.

Yousaf-Khan U, van der Aalst C, de Jong PA, Heuvelmans M, Scholten E, Walter J, Nackaerts K, Groen H, Vliegenthart R, Ten Haaf K, Oudkerk M, de Koning H.

Thorax. 2017 Sep;72(9):819-824. doi: 10.1136/thoraxjnl-2016-209892. Epub 2017 Mar 30.

PMID:
28360223
30.

Does selective pleural irradiation of malignant pleural mesothelioma allow radiation dose escalation? : A planning study.

Botticella A, Defraene G, Nackaerts K, Deroose C, Coolen J, Nafteux P, Vanstraelen B, Joosten S, Michiels LAW, Peeters S, De Ruysscher D.

Strahlenther Onkol. 2017 Apr;193(4):285-294. doi: 10.1007/s00066-017-1108-y. Epub 2017 Feb 14.

PMID:
28197653
31.

The challenge of molecular testing for clinical trials in advanced non-small cell lung cancer patients: Analysis of a prospective database.

Vrancken A, Lepers S, Peeters L, Oyen C, Dooms C, Nackaerts K, Verbeken E, Wauters I, Weynand B, Vansteenkiste J.

Lung Cancer. 2016 Dec;102:96-100. doi: 10.1016/j.lungcan.2016.11.003. Epub 2016 Nov 6.

PMID:
27987596
32.

Optimal gross tumor volume definition in lung-sparing intensity modulated radiotherapy for pleural mesothelioma: an in silico study.

Botticella A, Defraene G, Nackaerts K, Deroose CM, Coolen J, Nafteux P, Peeters S, Ricardi U, De Ruysscher D.

Acta Oncol. 2016 Dec;55(12):1450-1455. Epub 2016 Oct 12.

PMID:
27732127
33.

Detection of malignant pleural mesothelioma in exhaled breath by multicapillary column/ion mobility spectrometry (MCC/IMS).

Lamote K, Vynck M, Van Cleemput J, Thas O, Nackaerts K, van Meerbeeck JP.

J Breath Res. 2016 Sep 26;10(4):046001. doi: 10.1088/1752-7155/10/4/046001.

PMID:
27669062
34.

Asbestos bodies in bronchoalveolar lavage in the 21st century: a time-trend analysis in a clinical population.

Nuyts V, Vanhooren H, Begyn S, Nackaerts K, Nemery B.

Occup Environ Med. 2017 Jan;74(1):59-65. doi: 10.1136/oemed-2016-103710. Epub 2016 Aug 22.

PMID:
27550908
35.

A surprising cause of polycythaemia.

De Maeyer NE, Van Lommel S, Devos T, Buyse B, Nackaerts K.

Thorax. 2016 Oct;71(10):967-8. doi: 10.1136/thoraxjnl-2016-208610. Epub 2016 Jul 7. No abstract available.

PMID:
27388485
36.

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.

Yousaf-Khan U, van der Aalst C, de Jong PA, Heuvelmans M, Scholten E, Lammers JW, van Ooijen P, Nackaerts K, Weenink C, Groen H, Vliegenthart R, Ten Haaf K, Oudkerk M, de Koning H.

Thorax. 2017 Jan;72(1):48-56. doi: 10.1136/thoraxjnl-2016-208655. Epub 2016 Jun 30.

PMID:
27364640
37.

Selective mediastinal node irradiation in non-small cell lung cancer in the IMRT/VMAT era: How to use E(B)US-NA information in addition to PET-CT for delineation?

Peeters ST, Dooms C, Van Baardwijk A, Dingemans AM, Martinussen H, Vansteenkiste J, Decaluwé H, De Leyn P, Yserbyt J, Nackaerts K, De Wever W, Deroose CM, De Ruysscher D.

Radiother Oncol. 2016 Aug;120(2):273-8. doi: 10.1016/j.radonc.2016.05.023. Epub 2016 Jun 10.

PMID:
27291644
38.

Nicotine Dependence and Urinary Nicotine, Cotinine and Hydroxycotinine Levels in Daily Smokers.

Van Overmeire IP, De Smedt T, Dendale P, Nackaerts K, Vanacker H, Vanoeteren JF, Van Laethem DM, Van Loco J, De Cremer KA.

Nicotine Tob Res. 2016 Sep;18(9):1813-9. doi: 10.1093/ntr/ntw099. Epub 2016 Apr 15.

PMID:
27083213
39.

Pulmonary metastasis of a meningioma presenting as a solitary pulmonary nodule: 2 case reports.

Leemans J, Van Calenbergh F, Sciot R, Debiec-Rychter M, Decaluwe H, Nackaerts K.

Acta Clin Belg. 2016 Apr;71(2):107-10. doi: 10.1080/17843286.2015.1133002. Epub 2016 Feb 6.

PMID:
27075807
40.

Dynamic 68Ga-DOTATOC PET/CT and static image in NET patients. Correlation of parameters during PRRT.

Van Binnebeek S, Koole M, Terwinghe C, Baete K, Vanbilloen B, Haustermans K, Clement PM, Bogaerts K, Verbruggen A, Nackaerts K, Van Cutsem E, Verslype C, Mottaghy FM, Deroose CM.

Nuklearmedizin. 2016 Jun 28;55(3):104-14. doi: 10.3413/Nukmed-0742-15-05. Epub 2016 Apr 8.

PMID:
27056060
41.

Cost-effectiveness of retreatment with varenicline after failure with or relapse after initial treatment for smoking cessation.

Annemans L, Marbaix S, Nackaerts K, Bartsch P.

Prev Med Rep. 2015 Mar 14;2:189-95. doi: 10.1016/j.pmedr.2015.03.004. eCollection 2015.

42.

Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.

Stahel RA, Riesterer O, Xyrafas A, Opitz I, Beyeler M, Ochsenbein A, Früh M, Cathomas R, Nackaerts K, Peters S, Mamot C, Zippelius A, Mordasini C, Caspar CB, Eckhardt K, Schmid RA, Aebersold DM, Gautschi O, Nagel W, Töpfer M, Krayenbuehl J, Ribi K, Ciernik IF, Weder W.

Lancet Oncol. 2015 Dec;16(16):1651-8. doi: 10.1016/S1470-2045(15)00208-9. Epub 2015 Nov 2.

PMID:
26538423
43.

Lung cancer screening white paper: a slippery step forward?

Kauczor HU, Bonomo L, Gaga M, Nackaerts K, Peled N, Prokop M, Remy-Jardin M, von Stackelberg O, Sculier JP; European Society of Radiology (ESR) and the European Respiratory Society (ERS).

Eur Respir J. 2015 Nov;46(5):1521-2. doi: 10.1183/13993003.01103-2015. No abstract available.

44.

Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours.

Van Binnebeek S, Vanbilloen B, Baete K, Terwinghe C, Koole M, Mottaghy FM, Clement PM, Mortelmans L, Bogaerts K, Haustermans K, Nackaerts K, Van Cutsem E, Verslype C, Verbruggen A, Deroose CM.

Eur Radiol. 2016 Mar;26(3):900-9. doi: 10.1007/s00330-015-3882-1. Epub 2015 Jul 12.

PMID:
26162577
45.

ESR/ERS white paper on lung cancer screening.

Kauczor HU, Bonomo L, Gaga M, Nackaerts K, Peled N, Prokop M, Remy-Jardin M, von Stackelberg O, Sculier JP; European Society of Radiology (ESR); European Respiratory Society (ERS).

Eur Respir J. 2015 Jul;46(1):28-39. doi: 10.1183/09031936.00033015. Epub 2015 Apr 30.

46.

ESR/ERS white paper on lung cancer screening.

Kauczor HU, Bonomo L, Gaga M, Nackaerts K, Peled N, Prokop M, Remy-Jardin M, von Stackelberg O, Sculier JP; European Society of Radiology (ESR); European Respiratory Society (ERS).

Eur Radiol. 2015 Sep;25(9):2519-31. doi: 10.1007/s00330-015-3697-0. Epub 2015 May 1.

47.

Implicit attitudes towards smoking predict long-term relapse in abstinent smokers.

Spruyt A, Lemaigre V, Salhi B, Van Gucht D, Tibboel H, Van Bockstaele B, De Houwer J, Van Meerbeeck J, Nackaerts K.

Psychopharmacology (Berl). 2015 Jul;232(14):2551-61. doi: 10.1007/s00213-015-3893-2. Epub 2015 Mar 13.

PMID:
25761836
48.

Electronic nicotine delivery systems.

Nackaerts K, Joossens L.

Eur Respir J. 2015 Mar;45(3):858. doi: 10.1183/09031936.00205414. No abstract available.

49.

Skin lesions in a lung cancer patient.

Vrancken A, Verbeken E, Nackaerts K.

Acta Clin Belg. 2015 Jun;70(3):231-2. doi: 10.1179/2295333714Y.0000000115. Epub 2015 Jan 6. No abstract available.

PMID:
25560061
50.

Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases.

Rusch A, Ziltener G, Nackaerts K, Weder W, Stahel RA, Felley-Bosco E.

Lung Cancer. 2015 Jan;87(1):77-9. doi: 10.1016/j.lungcan.2014.10.017. Epub 2014 Nov 6.

PMID:
25468148

Supplemental Content

Loading ...
Support Center